Showing 37,901 - 37,920 results of 99,895 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (we decrease)) ))', query time: 1.75s Refine Results
  1. 37901

    A σ<sup>E</sup>-Mediated Temperature Gauge Controls a Switch from LuxR-Mediated Virulence Gene Expression to Thermal Stress Adaptation in <i>Vibrio alginolyticus</i> by Dan Gu (2191075)

    Published 2016
    “…An <i>rpoE</i> null <i>V</i>. <i>alginolyticus</i> mutant was unable to adapt to various stresses and was survival-deficient in fish. …”
  2. 37902

    An idealized view of the opportunity provided by a comparative and integrated oncology drug development path. by Ira Gordon (369869)

    Published 2013
    “…Factoring in additional costs for comparative studies with this approach of US$150,000 for studies conducted in the preclinical setting, US$250,000 for studies conducted before or during Phases I–II human trials and US$1 million for studies conducted before Phases II–III studies, the total cost of development is estimated at US$2.07 billion. The result may be a decrease in average clinical trial costs per approved drug from US$290 million to US$173 million <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-Adams1" target="_blank">[5]</a>.…”
  3. 37903

    Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study by Lena Björck (77400)

    Published 2016
    “…We assumed that there would be moderate improvements in smoking (5%), salt intake (1g/day) and physical inactivity (5% decrease) to continue recent, positive trends.…”
  4. 37904

    The changing trends of <i>f</i><sub><i>i</i></sub>, <i>i</i> ∈ {1, 2, 3, 4} with <i>v</i> for the Moran process (first row) and the Wright-Fisher process (second row) when <i>u</i>... by Yanling Zhang (6561)

    Published 2018
    “…For all <i>r</i>, The curve of <i>f</i><sub>4</sub> with <i>v</i> (fourth column) has an increasing trend with a small perturbation near <i>v</i> = 0.01. …”
  5. 37905

    Data_Sheet_1_Expression of vitamin D receptor, CYP24A1, and CYP27B1 in normal and inflamed canine pancreases.DOCX by Dohee Lee (432106)

    Published 2023
    “…This study showed that VDR expression decreased in inflamed pancreases and demonstrated CYP24A1 and CYP27B1 expression in the canine pancreas for the first time. …”
  6. 37906

    Core–Shell {Mn<sub>7</sub>⊂(Mn,Cd)<sub>12</sub>} Assembled from Core {Mn<sub>7</sub>} Disc by Ling-Yu Guo (3068232)

    Published 2017
    “…HR-ESI-MS was even more precise by revealing three prominent molecular species, Mn<sub>13</sub>Cd<sub>6</sub>, Mn<sub>14</sub>Cd<sub>5</sub> and Mn<sub>15</sub>Cd<sub>4</sub>, having a distribution of metals. …”
  7. 37907

    Table_1_Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.DOCX by Francisco Gascón-Giménez (12266840)

    Published 2023
    “…Mean EDSS had increased from 4.3 (SD: 1.9) to 4.8 (SD: 1.7) and almost half of the patients (41%) had worsened at least one point. After a median follow-up of 14.2 months (IQR: 6.5–27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). …”
  8. 37908

    Resource consumption of multi-substance users in the emergency room: A neglected patient group by Laurence Klenk (7434560)

    Published 2019
    “…<div><p>Background</p><p>Multi-substance use is accompanied by increased morbidity and mortality and responsible for a large number of emergency department (ED) consultations. …”
  9. 37909

    Table_1_Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.DOCX by Francisco Gascón-Giménez (12266840)

    Published 2023
    “…Mean EDSS had increased from 4.3 (SD: 1.9) to 4.8 (SD: 1.7) and almost half of the patients (41%) had worsened at least one point. After a median follow-up of 14.2 months (IQR: 6.5–27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). …”
  10. 37910

    Data Sheet 1_Effects of a polyphenol-rich extract blend, probiotics, and hydrolyzed fiber on quality of life and gut health markers in patients with irritable bowel syndrome—A rand... by Adrianna Wierzbicka (14130159)

    Published 2025
    “…Introduction<p>Irritable bowel syndrome (IBS) is the most prevalent functional bowel disorder impacting around 5%−10% of the general population worldwide. The pathogenesis remains unclear, however alterations in gut-brain axis play a critical role. …”
  11. 37911
  12. 37912
  13. 37913
  14. 37914

    DataSheet1_Examining the paradoxical effects of kratom: a narrative inquiry.PDF by Kirsten E. Smith (10716529)

    Published 2023
    “…Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). …”
  15. 37915

    Table 1_A retrospective analysis of 38,652 amniotic fluid karyotype.xlsx by Jianyu Ren (11429773)

    Published 2025
    “…Chromosome breakage was most common in chromosomes Y and 1, whereas deletions were most frequently detected in chromosomes X and 5. Isochromosomes mainly appeared in a mosaic form in chromosome X. …”
  16. 37916

    Supplementary Material for: Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease by Watanabe Y. (4129684)

    Published 2020
    “…We previously reported on the comprehensive profile of the urinary proteome of AD patients and identified proteins estimated to be significantly increased or decreased in AD patients by a label-free quantification method. …”
  17. 37917

    Effects of the AMPA Antagonist ZK 200775 on Visual Function: A Randomized Controlled Trial by Richard Bergholz (244473)

    Published 2010
    “…<div><h3>Background</h3><p>ZK 200775 is an antagonist at the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and had earned attention as a possible neuroprotective agent in cerebral ischemia. …”
  18. 37918

    Speed of processing training and depression in assisted and independent living: A randomized controlled trial by Marianne Smith (7512284)

    Published 2019
    “…Participants were randomized within sites to computerized SOPT vs. computerized crossword puzzles with a targeted dose of 10 hours of playtime at baseline plus 4 hours of booster training at five and eleven months. …”
  19. 37919

    Table 1_Obinutuzumab in systemic lupus erythematosus: a real-world experience.docx by Chunmei Wu (3202050)

    Published 2025
    “…</p>Methods<p>We retrospectively analyzed 56 SLE patients who received a single dose of obinutuzumab (1000 mg) at Renji Hospital, Shanghai Jiao Tong University School of Medicine between October 2021 and March 2024. …”
  20. 37920

    RPIA regulates colon cell proliferation through β-catenin expression in HCT116 cells. by Yu-Ting Chou (447778)

    Published 2018
    “…<i>AXIN2</i>, <i>Axis inhibition protein 2</i>; <i>CCND1</i>, <i>Cyclin D1</i>; <i>CCNE2</i>, <i>Cyclin E2</i>; <i>CTNNB1</i>, <i>CATENIN BETA 1</i>; pcDNA, pcDNA3 vector control; qPCR, quantitative PCR; RPIA, ribose-5-phosphate isomerase A; si-NC, negative control small interfering RNA; si-RPIA, RPIA small interfering RNA; TCF, T-cell transcription factor.…”